Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes

Peters plus syndrome (PPS) is a rare autosomal‐recessive disorder characterized by Peters anomaly of the eye, short stature, brachydactyly, dysmorphic facial features, developmental delay, and variable other systemic abnormalities. In this report, we describe screening of 64 patients affected with P...

Full description

Saved in:
Bibliographic Details
Published in:Clinical genetics Vol. 86; no. 2; pp. 142 - 148
Main Authors: Weh, E., Reis, L.M., Tyler, R.C., Bick, D., Rhead, W.J., Wallace, S., McGregor, T.L., Dills, S.K., Chao, M.-C., Murray, J.C., Semina, E.V.
Format: Journal Article
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01-08-2014
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Peters plus syndrome (PPS) is a rare autosomal‐recessive disorder characterized by Peters anomaly of the eye, short stature, brachydactyly, dysmorphic facial features, developmental delay, and variable other systemic abnormalities. In this report, we describe screening of 64 patients affected with PPS, isolated Peters anomaly and PPS‐like phenotypes. Mutations in the coding region of B3GALTL were identified in nine patients; six had a documented phenotype of classic PPS and the remaining three had a clinical diagnosis of PPS with incomplete clinical documentation. A total of nine different pathogenic alleles were identified. Five alleles are novel including one frameshift, c.168dupA, p.(Gly57Argfs*11), one nonsense, c.1234C>T, p.(Arg412*), two missense, c.1045G>A, p.(Asp349Asn) and c.1181G>A, p.(Gly394Glu), and one splicing, c.347+5G>T, mutations. Consistent with previous reports, the c.660+1G>A mutation was the most common mutation identified, seen in eight of the nine patients and accounting for 55% of pathogenic alleles in this study and 69% of all reported pathogenic alleles; while two patients were homozygous for this mutation, the majority had a second rare pathogenic allele. We also report the absence of B3GALTL mutations in 55 cases of PPS‐like phenotypes or isolated Peters anomaly, further establishing the strong association of B3GALTL mutations with classic PPS only.
Bibliography:ArticleID:CGE12241
National Institutes of Health - No. R01EY015518; No. R21DC010912
Children's Hospital of Wisconsin (EVS)
ark:/67375/WNG-QFFSSBRP-L
Table S1. Phenotype summary of B3GALTL-negative PPS-like cases reported in this study and literatureTable S2. Summary of rare likely benign variants identified in B3GALTLFigure S1. (a) Novel B3GALTL mutations in Peters plus syndrome patients identified in this study. The position of each mutation is indicated with a black arrow. (b) Results of TaqMan copy number assays targeting 5′ (intron 1) and 3′ (exon 14) regions of B3GALTL that were performed on DNA samples from Patients 1, 3 and 8, who appeared homozygous for the common c.660+1G>A splicing mutation, alongside a control sample with diploid B3GALTL copy number; haploid copy number for both probes was detected for Patient 1 (arrow) while Patients 3 and 8 were diploid for both probes. (c) Evolutionary conservation of amino acid residues affected by missense mutations identified in Patients 7 and 9; note 100% conservation of both positions in vertebrates (box).
Clinical and Translational Science Award (CTSA) program - No. 1UL1RR031973
istex:EE28BC017398721D30A913124B950535E464E2B7
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
These authors contributed equally to this work
ISSN:0009-9163
1399-0004
DOI:10.1111/cge.12241